Tracking Balance and Walking Recovery After Stroke
FOSTER
Mapping the Time Course of Recovery of Sitting and Standing Balance and Walking After Stroke
1 other identifier
observational
120
1 country
1
Brief Summary
This study aims to understand how balance and walking abilities recover after a stroke, using innovative tools like an interactive assessment game. By observing patients over time, the investigators seek to identify recovery patterns that can improve rehabilitation strategies tailored to individual needs. Interacting with a game designed to assess balance and movement, participants will perform tasks involving sitting balance, standing balance, and gait initiation. The game measures aspects like reaction time, movement accuracy, and postural control, providing detailed insights into recovery progress. These data will validate prediction models to support personalized care. The study is non-invasive, does not interfere with usual care, and prioritizes patient safety. The investigators' ultimate goal is to enhance the understanding of recovery, leading to better care and improved quality of life for stroke survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2025
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 29, 2024
CompletedStudy Start
First participant enrolled
January 7, 2025
CompletedFirst Posted
Study publicly available on registry
February 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 9, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 9, 2028
February 27, 2025
February 1, 2025
3.9 years
November 29, 2024
February 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Postural control
Postural control during dynamic tasks (sitting, standing, gait initiation) measured using wearable sensors (e.g., IMUs) and other biomechanical measurement systems (e.g., force plates, Kinect cameras).
Baseline, 3, 5, 8, 12, and 24 weeks post-stroke (or until discharge)
Weight distribution
Weight distribution during balance and movement tasks (standing, gait initiation) using force plates.
Baseline, 3, 5, 8, 12, and 24 weeks post-stroke (or until discharge)
Movement coordination
Movement coordination assessed during functional motor tasks (sitting, standing, gait initiation) using wearable sensors (e.g., IMUs), force plates, and Kinect camera.
Baseline, 3, 5, 8, 12, and 24 weeks post-stroke (or until discharge)
Neuromuscular activity
Neuromuscular activity evaluated during dynamic tasks (sitting, standing, gait initiation) using muscle activity measurement systems (e.g., EMG sensors).
Baseline, 3, 5, 8, 12, and 24 weeks post-stroke (or until discharge)
Secondary Outcomes (17)
Reaction time
Baseline, 3, 5, 8, 12, and 24 weeks post-stroke (or until discharge)
Movement time
Baseline, 3, 5, 8, 12, and 24 weeks post-stroke (or until discharge)
Reaching or stepping accuracy
Baseline, 3, 5, 8, 12, and 24 weeks post-stroke (or until discharge)
Upper limb dynamics
Baseline, 3, 5, 8, 12, and 24 weeks post-stroke (or until discharge)
Error rate during dual-task performance
Baseline, 3, 5, 8, 12, and 24 weeks post-stroke (or until discharge)
- +12 more secondary outcomes
Study Arms (1)
Patients in the first 6 months after stroke
Participants in this study will be adults aged 18 years or older, following a supratentorial stroke, as defined by the World Health Organization (WHO). Inclusion will occur as soon as possible after hospital admission. Participants must be capable of providing informed consent, which may be written, verbal, or provided by proxy if necessary. Exclusion criteria include the presence of other neurological or orthopedic disorders (e.g., Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis) that impair motor function, severe complicating comorbidities imposing health risks (e.g., cardiovascular instability), significant deficits in communication, memory, or understanding (defined by a score of less than 21 on the Montreal Cognitive Assessment (MoCA)), and insufficient knowledge of Dutch, French, German, or English.
Interventions
Description: Patients after stroke who meet the in- and exclusion criteria will be examined up to 6 times during the first 6 months after their stroke.
Eligibility Criteria
Patients in the first 6 months after stroke: Participants in this study will be adults aged 18 years or older, following a supratentorial stroke, as defined by the World Health Organization (WHO).
You may qualify if:
- Adult (≥ 18 years)
- Diagnosis of supratentorial stroke (as defined by the WHO)
- Able to provide written or verbal informed consent (written, verbal or by proxy)
You may not qualify if:
- Other neurological/orthopedic disorders (e.g., Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis) leading to impairments in motor function.
- Severe complicating comorbidities imposing health risks (e.g., cardiovascular instability)
- Severe deficits in communication, memory or understanding (Montreal Cognitive Assessment test (MoCA) \< 21); and
- Insufficient knowledge of Dutch, French or English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vrije Universiteit Brussellead
- Universitair Ziekenhuis Brusselcollaborator
- Revalidatieziekenhuis InkendaaIcollaborator
Study Sites (1)
Inkendaal rehabilitation hospital
Sint-Pieters-Leeuw, Brussels Capital, 1602, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 24 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 29, 2024
First Posted
February 4, 2025
Study Start
January 7, 2025
Primary Completion (Estimated)
December 9, 2028
Study Completion (Estimated)
December 9, 2028
Last Updated
February 27, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
This study is part of the EU Horizon 2020 TARGET project, following its DMP to ensure data is handled ethically, legally, and sustainably in line with FAIR principles (Findability, Accessibility, Interoperability, Reusability). The plan ensures systematic organization, quality consistency via standardized procedures, and compliance with GDPR, national laws, and EU requirements. Personal data is processed securely, only when necessary for project objectives, with approvals and written consent from participants. Methods include interviews, surveys, workshops, and questionnaires. Data is stored with robust backup and preservation strategies to prevent loss and ensure future usability. Sharing is (currently) restricted to the consortium under a signed data transfer agreement, with external sharing undecided. Data not publicly available includes: third-party data without permission for public release, data compromising IP protection, and participant data that cannot be fully anonymized.